Enhanced lymphokine-activated killer cell activity by an immunomodulator, Roquinimex.

doi:10.1038/bjc.1995.536

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Enhanced lymphokine-activated killer cell activity by an immunomodulator, Roquinimex.

British journal of cancer - 1 Dec 1995

Vaz F, Silva M R, Ascensao J L

Abstract excerpt

Roquinimex (Roq) is an immunomodulator known to stimulate cellular immune responses. It is currently used for immunotherapy after bone marrow transplantation (BMT). One of the major features of this compound is an enhancement of natural killer (NK) cell activity and numbers. We studied the in vit...

Topics

Adjuvants, Immunologic
Bone Marrow
Bone Marrow Cells
Bone Marrow Purging
Cell Count
Cell Division
Cells, Cultured
Cyclophosphamide
Hematopoietic Stem Cells
Humans
Hydroxyquinolines
Killer Cells, Lymphokine-Activated
Killer Cells, Natural
Leukemia, Erythroblastic, Acute
Leukocytes, Mononuclear
Lymphocyte Activation
Phenotype
Stimulation, Chemical

Source

Open in PubMed Open full text

Identifiers

PMID: 8519666
DOI: 10.1038/bjc.1995.536
PMCID: PMC2034089

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-8519666-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics